<DOC>
	<DOCNO>NCT01429337</DOCNO>
	<brief_summary>The purpose international study assess effect vary degree impair hepatic function compare normal hepatic function ( Child-Pugh classification ) pharmacokinetics safety midostaurin .</brief_summary>
	<brief_title>Pharmacokinetics Safety Midostaurin Subjects With Impaired Hepatic Function Subjects With Normal Hepatic Function</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>4'-N-benzoylstaurosporine</mesh_term>
	<mesh_term>Staurosporine</mesh_term>
	<criteria>â€¢ Subjects must able communicate well Investigator comply requirement study . Significant neurologic psychiatric disorder could compromise participation study . Subjects know ongoing alcohol and/or drug abuse within 1 month prior dose evidence abuse . Subjects cotinine level great 500ng/mL consider smoker enrol . Consumption alcohol within 3 day prior dose study . Women childbearing potential unless use highly effective contraception method length study least least 3 month last exposure midostaurin . Highly effective method include : Total abstinence , female sterilization male partner sterilization . Or use combination ( a+b ) : ) Placement intrauterine device intrauterine system , b ) barrier method contraception Sexually active male unless use condom intercourse take midostaurin least 3 month last exposure drug . A condom require use also vasectomize men . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Hepatic impair patient</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>Varying degree hepatic impairment</keyword>
</DOC>